•  
  •  
  •  
  •  

2025-12-23 14:33:37

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Aurionpro's Integro Platform to Power Global Lending Modernization for a Top Singaporean Bank
  • Biocon Biologics Secures Full Global Rights to Biosimilar Adalimumab through Expanded FKB In-Licensing Agreement
  • Puravankara announces acquisition of 53-acre land parcel in Bengaluru with GDV of over Rs 4,800 crores
  • Deccan Gold Mines Ltd to invest in a tungsten project in Spain
  • Glenmark Pharmaceuticals Inc., USA launches Epinephrine Injection USP, 30 mg/30 mL (1 mg/mL) Multiple-Dose Vial

Keywords Selected:  PatanjaliFoods

Stock Report

  • Patanjali Foods Limited declares interim dividend of Rs. 1.75
  • Patanjali Foods Limited signs MOU with MoFPI
  • Patanjali Foods Limited recommends final dividend of Rs. 2
  • Patanjali Foods Ltd Q4FY25 PAT at Rs. 358.53 crores
  • Patanjali Foods Ltd commences commercial production at Niglok Palm Oil Processing Mill
  • LIC increases stake in Patanjali Foods Ltd
  • Patanjali Foods Ltd Q2 FY2024-25 net profit rises to Rs. 308.97 crores
  • Patanjali Foods Ltd Q1 FY2025 net profit increases to Rs. 262.90 crores
  • Home and Personal Care business acquisition by Patanjali Foods Ltd on slump sale basis with major brands to boost FMCG portfolio
  • Patanjali Foods Ltd Q4 FY2023-24 net profit declines to Rs. 206.31 crores
  • Patanjali Foods Limited receives a proposal to acquire non-food business from Patanjali Ayurved Limited
  • Patanjali Foods Limited - Quarterly Update - Q4FY24
  • Patanjali Foods Limited declares interim dividend of Rs. 6
  • Patanjali Foods Limited - Quarterly Update: Q2FY24
  • Patanjali Foods Ltd inks MOU with Telangana Government for food processing unit
  • Patanjali Foods Ltd Q3 FY2022-23 net profit climbs QoQ to Rs. 269.18 crores
  • Patanjali Foods Ltd lays foundation stone for Oil Palm Mill in Arunachal Pradesh

Latest Post

  • Aurionpro's Integro Platform to Power Global Lending Modernization for a Top Singaporean Bank
  • Biocon Biologics Secures Full Global Rights to Biosimilar Adalimumab through Expanded FKB In-Licensing Agreement
  • Puravankara announces acquisition of 53-acre land parcel in Bengaluru with GDV of over Rs 4,800 crores
  • Deccan Gold Mines Ltd to invest in a tungsten project in Spain
  • Glenmark Pharmaceuticals Inc., USA launches Epinephrine Injection USP, 30 mg/30 mL (1 mg/mL) Multiple-Dose Vial


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024